- Home
- ATAI vs ANGO Comparison
ATAI vs ANGO Comparison
Compare ATAI & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- ANGO
- Stock Information
- Founded
- ATAI 2018
- ANGO 1988
- Country
- ATAI Germany
- ANGO United States
- Employees
- ATAI N/A
- ANGO N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- ANGO Medical/Dental Instruments
- Sector
- ATAI Health Care
- ANGO Health Care
- Exchange
- ATAI Nasdaq
- ANGO Nasdaq
- Market Cap
- ATAI 271.6M
- ANGO 279.1M
- IPO Year
- ATAI 2021
- ANGO 2004
- Fundamental
- Price
- ATAI $1.37
- ANGO $9.78
- Analyst Decision
- ATAI Strong Buy
- ANGO Strong Buy
- Analyst Count
- ATAI 4
- ANGO 3
- Target Price
- ATAI $9.00
- ANGO $13.00
- AVG Volume (30 Days)
- ATAI 2.1M
- ANGO 511.4K
- Earning Date
- ATAI 03-17-2025
- ANGO 04-02-2025
- Dividend Yield
- ATAI N/A
- ANGO N/A
- EPS Growth
- ATAI N/A
- ANGO N/A
- EPS
- ATAI N/A
- ANGO N/A
- Revenue
- ATAI $308,000.00
- ANGO $286,498,000.00
- Revenue This Year
- ATAI N/A
- ANGO N/A
- Revenue Next Year
- ATAI $20.00
- ANGO $6.63
- P/E Ratio
- ATAI N/A
- ANGO N/A
- Revenue Growth
- ATAI N/A
- ANGO N/A
- 52 Week Low
- ATAI $0.78
- ANGO $5.26
- 52 Week High
- ATAI $2.85
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- ATAI 38.64
- ANGO 48.76
- Support Level
- ATAI $1.37
- ANGO $8.95
- Resistance Level
- ATAI $1.52
- ANGO $9.84
- Average True Range (ATR)
- ATAI 0.12
- ANGO 0.47
- MACD
- ATAI -0.02
- ANGO 0.09
- Stochastic Oscillator
- ATAI 13.25
- ANGO 85.99
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.